While Juno boasts a number of products in its pipeline, its crown jewel is called liso-cel, which is also called JCAR017 ... With shares currently trading hands at a cheap valuation -- Celgene's stock can be purchased right now for around 12 …
CEL-SCI Corporation (NYSE American: CVM) announced today that the outstanding Series S warrants (CUSIP number 150837177) that are publicly traded under the symbol “CVM WS” on the NYSE American have been repriced to $3.00 …
Celgene Corp. (NASDAQ: CELG) owns ex-U.S. rights to Juno Therapeutics' (NASDAQ: JUNO) lead drug, liso-cel (formerly JCAR017), and it owns nearly 10% of Juno Therapeutics' stock, yet that may not be enough to satisfy Celgene's desire …
Not surprisingly, this rate is more than double the growth rate of the US stock market as a whole. Below, I will examine the sector growth prospects, as well as evaluate whether CEL-SCI is lagging or leading in the industry. Check out our latest …
Scotch, the world's favourite whisky, will be celebrated across the globe on Thursday February 8 th with a series of red …
So far, the data suggests that liso-cel could be the safest and most effective CAR-T developed ... 10 stocks we like better than Juno Therapeutics When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, …